Clinical trial / 2009
Supplementation with vitamin E, beta carotene, or vitamin C did not slow cognitive change over 5.4 years in older women with or at risk for cardiovascular disease.
In a substudy of the Women's Antioxidant Cardiovascular Study, 2,824 women aged >=65 years were tested 4 times over 5.4 years to evaluate the effects of vitamin E (402 mg alternate days), beta carotene (50 mg alternate days), and vitamin C (500 mg daily). Vitamin E and beta carotene were not associated with slower rates of cognitive change compared to placebo (mean difference in change: -0.01, 95% CI -0.05 to 0.04, P=0.78 for vitamin E; 0.03, 95% CI -0.02 to 0.07, P=0.28 for beta carotene). Vitamin C was associated with better performance at the final assessment (mean difference 0.13, 95% CI 0.06 to 0.20, P=0.0005) but was not associated with cognitive change over time (mean difference 0.02, 95% CI -0.03 to 0.07, P=0.39).
- Study type
- Randomized controlled trial (substudy)
- Who was studied
- 2,824 women aged >=65 years with CVD or >=3 coronary risk factors
- What was measured
- Cognitive change over time assessed via global composite score over 5.4 years
THE PAPER
Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study.
Kang JH, Cook NR, Manson JE, Buring JE, Albert CM, Grodstein F. Circulation, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.